Can you provide the average price target for IMAX CORP stock?
18 analysts have analysed IMAX and the average price target is 46.55 USD. This implies a price increase of 25% is expected in the next year compared to the current price of 37.24.
NYSE:IMAX • CA45245E1097
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMAX CORP (IMAX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2026-04-20 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-04-08 | Seaport Global | Maintains | Buy -> Buy |
| 2026-03-02 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-02-26 | Macquarie | Maintains | Outperform -> Outperform |
| 2026-02-26 | Benchmark | Maintains | Buy -> Buy |
| 2026-02-26 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-24 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-02-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2026-01-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-01-15 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-12-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-15 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-12-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-12-08 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-12-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-25 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-10-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-24 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-24 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-14 | Roth Capital | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 374.839M 24.61% | 352.208M -6.04% | 410.212M 16.47% | 447.84M 9.17% | 482.22M 7.68% | 510.22M 5.81% | N/A | N/A | |
| EBITDA YoY % growth | 112.762M 78.70% | 111.099M -1.47% | 154.277M 38.86% | 203.65M 32.00% | 217.04M 6.58% | 246.97M 13.79% | 255.11M 3.30% | 276.53M 8.40% | |
| EBIT YoY % growth | 54.547M 565.21% | 47.838M -12.30% | 94.503M 97.55% | 117M 23.81% | 137.18M 17.25% | 156.58M 14.14% | 184.9M 18.09% | 206.4M 11.63% | |
| Operating Margin | 14.55% | 13.58% | 23.04% | 26.13% | 28.45% | 30.69% | N/A | N/A | |
| EPS YoY % growth | 0.94 1,242.86% | 0.95 1.06% | 1.44 51.58% | 1.72 19.37% | 2.00 16.50% | 2.27 13.18% | 2.75 21.51% | 3.07 11.48% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.19 47.35% | 0.38 45.98% | 0.50 6.93% | 0.64 11.06% | 0.22 15.34% | 0.46 21.90% | 0.59 17.64% | 0.70 9.11% | 0.25 14.04% | 0.42 -9.17% | 0.53 -10.11% | 0.92 31.06% |
| Revenue Q2Q % growth | 84.319M -2.71% | 104.96M 14.48% | 119.25M 11.81% | 141.87M 13.31% | 87.767M 4.09% | 113.64M 8.27% | 126.68M 6.23% | 154.5M 8.90% | 93.261M 6.26% | 115.94M 2.02% | 119.1M -5.98% | 177.46M 14.86% |
| EBITDA Q2Q % growth | 33.906M 8.16% | 46.449M 2.11% | 56.502M -22.62% | 66.237M -28.56% | 35.6M 5.00% | 52.252M 12.49% | 62.756M 11.07% | 72.796M 9.90% | 42.897M 20.50% | 51.636M -1.18% | 61.756M -1.59% | 91.038M 25.06% |
| EBIT Q2Q % growth | 14.589M -14.51% | 24.837M 55.73% | 35.575M 24.65% | 41.456M 25.82% | 15.106M 3.54% | 36.257M 45.98% | 43.926M 23.47% | 50.87M 22.71% | 27.254M 80.42% | 34.012M -6.19% | 45.095M 2.66% | 72.063M 41.66% |
All data in USD
18 analysts have analysed IMAX and the average price target is 46.55 USD. This implies a price increase of 25% is expected in the next year compared to the current price of 37.24.
IMAX CORP (IMAX) will report earnings on 2026-04-30, after the market close.
The consensus EPS estimate for the next earnings of IMAX CORP (IMAX) is 0.19 USD and the consensus revenue estimate is 84.32M USD.
The expected long term growth rate for IMAX CORP (IMAX) is 7.25%.